Previous Close | 5.80 |
Open | 5.80 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 15.00 |
Expire Date | 2024-10-18 |
Day's Range | 5.80 - 5.80 |
Contract Range | N/A |
Volume | |
Open Interest | 3 |
BOSTON, May 23, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
BOSTON, May 09, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.